Pharmaceutical Intermediate

Eseroline

98+%

tert-butyl (R)-1-(Methoxycarbonyl)-3-(2,4,5-trifluorophenyl)propan-2-ylcarbaMate

95+%

tert-butyl 2-(3-(2-aMino-2-oxoacetyl)-1-benzyl-2-ethyl-1H-indol-4-yloxy)acetate

98+%

Tert-Butyl 2-(2,3-difluoro-6-nitrophenyl)-3-oxobutanoate

98+%

Resolving Agent HBTM-R

98+%

Pinocarvon

98+%

Fondaparinux Sodium N-3 Intermediate; a-D-Glucopyranoside, Methyl O-2-azido-2-deoxy-3,4-bis-O-(phenylMethyl)-a-D-glucopyranosyl-(14) -O-2,3-bis-O-(phenylMethyl)-b-D-glucopyranuronosyl-(14)-O-2-azido- 2-deoxy-a-D-glucopyranosyl-(14)-O-3-O-(phenylMethyl)-a-L-idopyranu ronosyl-(14)-2-deoxy-2

98+%

N-(2,6-dimethylphenyl)-2-piperazineacetamide(CVT-2738)

98+%

(3-Oxo-1,3-dihydro-isobenzofuran-1-yl)-phosphonic acid dimethyl ester

98+%

BSF-466895

98+%

Chlormethine hydrochloride | Mechlorethamine hydrochloride

98+%

6-Methylcoumarin

98+%

Dydrogesterone Bis(Ethylene Acetal)

98+%

tert-Butyl [(1S,2R)-1-benzyl-2-hydroxy-3-(isobutylamino)propyl]carbamate

98+%